Invesaro

Stocks Health care KIDS

NASDAQ · Health care

Orthopediatrics Corp (KIDS)

Orthopediatrics Corp brought in $264.1M of revenue over the twelve months to September 30, 2026, up 16.1% from a year earlier. It posted a net loss of $33.9M. In fiscal 2025 capital spending exceeded operating cash flow by $16M. At September 30, 2026 it held $17.1M in cash against $104.6M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on October 28, 2026.

Free, no password. An email when KIDS files with the SEC.

Price
$33.19
-2.35% on the day · November 10, 2026
52-week range $14.42 to $34.53
Market cap
$866.6M
Revenue (last 12 months)
$264.1M
+16.1% year on year
Net margin
-12.8%

Key facts about Orthopediatrics Corp

Net worth
Orthopediatrics Corp has a market value (market cap) of $866.6M at the latest share price, and shareholders' equity of $339.4M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $236.3M (+15.4% year on year), with a net loss of $39.6M. Over the 12 months to September 30, 2026: revenue $264.1M, net loss $33.9M.
Cash flow
In fiscal 2025 operations used $4.9M of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on October 28, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
Next earnings report
Orthopediatrics Corp's next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

What Orthopediatrics Corp does

Orthopediatrics Corp is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker KIDS.

Revenue and profit by year

Revenue
FY18: $57.6M $57.6M FY18FY19: $72.6M $72.6M FY19FY20: $71.1M $71.1M FY20FY21: $98M $98M FY21FY22: $122.3M $122.3M FY22FY23: $148.7M $148.7M FY23FY24: $204.7M $204.7M FY24FY25: $236.3M $236.3M FY25
Net income
FY18: -$12M -$12M FY18FY19: -$13.7M -$13.7M FY19FY20: -$32.9M -$32.9M FY20FY21: -$16.3M -$16.3M FY21FY22: $1.3M $1.3M FY22FY23: -$21M -$21M FY23FY24: -$37.8M -$37.8M FY24FY25: -$39.6M -$39.6M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$236.3M-$39.2M-$39.6M-$1.69-$16M
2024$204.7M-$35M-$37.8M-$1.64-$41.3M
2023$148.7M-$26.8M-$21M-$0.92-$43.9M
2022$122.3M-$25.4M$1.3M$0.06-$31.8M
2021$98M-$18M-$16.3M-$0.84-$21.2M
2020$71.1M-$26.8M-$32.9M-$1.82-$29M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around January 11, 2027.

Estimated from its filing rhythm: 52 weeks after its report of January 12, 2026. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where KIDS ranks in Health care

Revenue$236.3M
#259 of 751 in Health care · Top 34%
Revenue growth+15.4%
#224 of 532 in Health care · Top 42%
Net margin-16.8%
#313 of 544 in Health care · Bottom 43%
Free cash flow margin-6.8%
#284 of 490 in Health care · Bottom 42%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

Fiscal yearPer sharePaid outOf profit
2019n/a$0n/a
2018n/a$0n/a
2017n/a$6Mn/a
2017n/a$0n/a
2015n/a$0n/a

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Orthopediatrics Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 28, 2026
    Quarterly report 10-Q · period to September 30, 2026Revenue rose 19% to $72.7M versus the same quarter last year; diluted EPS -$0.25 versus -$0.50.
  2. October 27, 2026
  3. October 27, 2026
  4. September 11, 2026
  5. September 1, 2026
  6. August 5, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 15% to $70.5M versus the same quarter last year; diluted EPS -$0.30 versus -$0.30.
  7. August 4, 2026
  8. August 4, 2026
  9. July 15, 2026
  10. June 4, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 11, 2026. Insider transactions on SEC

Insider trades

What the people running Orthopediatrics Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $46.7M worth of shares in the last 90 days and bought none on the open market.

Bought (open market)
$0
last 90 days
Sold
$46.7M
last 90 days
Net sold
2,100,000
$46.7M
DateInsiderWhatSharesPriceValueFiling
September 10, 2026 Pritzker Jennifer N.10% owner Soldindirect 302,369 $21.01 $6.4M Form 4
September 10, 2026 Squadron Capital LLC10% owner Sold 302,369 $21.01 $6.4M Form 4
September 10, 2026 Pelizzon David RDirector, 10% owner Soldindirect 302,369 $21.01 $6.4M Form 4
September 2, 2026 Pritzker Jennifer N.10% owner Soldindirect 22,500 $23.35 $525.4K Form 4
September 2, 2026 Squadron Capital LLC10% owner Sold 22,500 $23.35 $525.4K Form 4
September 2, 2026 Pelizzon David RDirector, 10% owner Soldindirect 22,500 $23.35 $525.4K Form 4
September 1, 2026 Pritzker Jennifer N.10% owner Soldindirect 10,131 $23.10 $234K Form 4
September 1, 2026 Squadron Capital LLC10% owner Sold 10,131 $23.10 $234K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns KIDS

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
David R. Pelizzon13D, may seek influence with 3 related filers 23.9% 6,246,148 September 11, 2026

Latest filings below 5%: Millennium Management LLC 3.2% (July 15, 2026); Brown Capital Management, LLC 4.31% (November 12, 2025).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 120 managers reported a position.

HolderSharesValueChange on quarter
Brown Advisory Inc1,678,983$32.1M+160,965
BlackRock, Inc.1,272,714$24.3M+98,668
Braidwell LP1,100,370$21.1M0
Granahan Investment Management, LLC1,085,964$20.8M+189,223
Millennium Management LLC816,830$15.6M-420,069
Wellington Management Group Llp794,309$15.2M-93,135
Vanguard Capital Management LLC755,624$14.5M+37,448
Soleus Capital Management, L.P.732,144$14M+116,697
Morgan Stanley693,387$13.3M-447,731
Wasatch Advisors LP515,677$9.9M+186,357
Nantahala Capital Management, LLC484,684$9.3M+285,235
Dimensional Fund Advisors LP480,848$9.2M-65,778
Geode Capital Management, LLC452,354$8.7M+19,686
State Street Corp391,630$7.5M-22,411
Citadel Advisors LLC334,651$6.4M+149,258
Roubaix Capital, LLC306,564$5.9M+16,517
Goldman Sachs Group Inc304,712$5.8M-37,731
AIGH Capital Management LLC269,765$5.2Mnew
AWM Investment Company, Inc.237,169$4.5M0
Nuveen, LLC222,869$4.3M+58,882

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

16 insiders reported holding 20,233,664 shares in total, about $671.6M at the last price.

HolderSharesAs of
Pelizzon David RDirector, 10% owner 6,246,1486,201,764 held indirectly September 10, 2026
Pritzker Jennifer N.10% owner 6,201,7646,201,764 held indirectly September 10, 2026
Squadron Capital LLC10% owner 6,201,764 September 10, 2026
Bailey David RPresident and CEO, Director 417,160 June 9, 2026
Hite FredCOO and CFO, Director 277,477 March 16, 2026
Hauser Joseph WPres. Trauma & Def. Correction 194,767 March 16, 2026
Odle Gregory APresident of Scoliosis 187,735 March 16, 2026
Throdahl Mark CDirector 179,317 June 9, 2026
Gerritzen Daniel JGeneral Counsel and Secretary 147,054 May 13, 2026
Hughes Bryan WDirector 32,663 June 9, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about KIDS

What does Orthopediatrics Corp do?

Orthopediatrics Corp is a company in the Health care sector, listed on NASDAQ as KIDS. Its shares trade on NASDAQ under the ticker KIDS.

What is Orthopediatrics Corp's net worth?

Orthopediatrics Corp has a market value (market cap) of $866.6M at the latest share price, and shareholders' equity of $339.4M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Orthopediatrics Corp profitable?

No. Over the twelve months to September 30, 2026 it reported a net loss of $33.9M on revenue of $264.1M.

How much revenue does Orthopediatrics Corp make?

Over the twelve months to September 30, 2026 Orthopediatrics Corp reported revenue of $264.1M. That is 16.1% more than a year earlier.

When did Orthopediatrics Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on October 28, 2026. It covers the period to September 30, 2026.

When is Orthopediatrics Corp's next earnings report?

Orthopediatrics Corp's next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare KIDS with

Compare KIDS with any company

Follow KIDS

Get an email when Orthopediatrics Corp files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when KIDS files with the SEC.

Where the numbers come from

Financial figures are the values Orthopediatrics Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.